Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients.

MLA

Modesto, A., et al. “Tolerance and Efficacy of Dose Escalation Using IMRT Combined with Chemotherapy for Unresectable Esophageal Carcinoma: Long-Term Results of 51 Patients.” Cancer Radiotherapie : Journal de La Societe Francaise de Radiotherapie Oncologique, vol. 24, no. 2, Apr. 2020, pp. 88–92. EBSCOhost, https://doi.org/10.1016/j.canrad.2020.01.006.

APA

Modesto, A., Dalmasso, C., Lusque, A., Vieillevigne, L., Izar, F., Moyal, E., Carrère, N., Guimbaud, R., & Rives, M. (2020). Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients. Cancer Radiotherapie : Journal de La Societe Francaise de Radiotherapie Oncologique, 24(2), 88–92. https://doi.org/10.1016/j.canrad.2020.01.006

Chicago

Modesto, A, C Dalmasso, A Lusque, L Vieillevigne, F Izar, E Moyal, N Carrère, R Guimbaud, and M Rives. 2020. “Tolerance and Efficacy of Dose Escalation Using IMRT Combined with Chemotherapy for Unresectable Esophageal Carcinoma: Long-Term Results of 51 Patients.” Cancer Radiotherapie : Journal de La Societe Francaise de Radiotherapie Oncologique 24 (2): 88–92. doi:10.1016/j.canrad.2020.01.006.